Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04418180Completed
Randomised, double-blind trial of fenofibrate in unconjugated hyperbilirubinemia (UHB) (3 arms), sponsored by Mansoura University. Primary endpoint: Total Serum Bilirubin at 72 hours. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04418180.